BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. World J Hepatol 2015; 7(3): 289-303 [PMID: 25848459 DOI: 10.4254/wjh.v7.i3.289] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 88] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Diakite M, Shaw-saliba K, Lau C. Malignancy and viral infections in Sub-Saharan Africa: A review. Front Virol 2023;3. [DOI: 10.3389/fviro.2023.1103737] [Reference Citation Analysis]
2 Mathew A, Ismael N, Meeds H, Vubil A, Zicai AF, Mabunda N, Blackard JT. Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique. PLoS One 2023;18:e0281855. [PMID: 36795797 DOI: 10.1371/journal.pone.0281855] [Reference Citation Analysis]
3 Campos-valdez M, Feustel S, Monroy-ramírez HC, Barrientos-salcedo C, Ayón-pérez MF, Ramos-márquez ME, Fernández-galindo DA, Silva-gómez JA, Santos A, Armendáriz-borunda J, Sánchez-orozco LV. Influence of C107R mutation from hepatitis B virus genotype H on in vitro hepatitis B surface antigen detection and IFN-β-1a treatment. Future Virology 2022. [DOI: 10.2217/fvl-2021-0347] [Reference Citation Analysis]
4 Anejo-Okopi J, Okeke E, Davwar PM, Onwuamah C, Onywera H, Omaiye P, Duguru M, Okojokwu OJ, Ujah OI, Jonathan B, George CA, Crown RS, Yakubu FB, Sokei JO, Okoli LC, Audu O, Inzaule SC, Abah IO, Agaba P, Agbaji OO, Sagay AS, Hawkins C. Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria. Afr J Lab Med 2022;11:1677. [PMID: 36337771 DOI: 10.4102/ajlm.v11i1.1677] [Reference Citation Analysis]
5 Saedi E, Derakhshan M, Shamsian AA, Tahaghoghi Hajghorbani S, Movaqar A, Youssefi M, Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Parasitology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Parasitology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. A Lamivudine/ Entacavir Resistance Mutations Among Treatment Naïve Chronic HBV Infected Patients Mashhad, Iran. Iran J Med Microbiol 2022;16:376-382. [DOI: 10.30699/ijmm.16.5.376] [Reference Citation Analysis]
6 Bonino F, Colombatto P, Brunetto MR. HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History. Viruses 2022;14:1691. [PMID: 36016312 DOI: 10.3390/v14081691] [Reference Citation Analysis]
7 Bezerra CS, Portilho MM, Barbosa JR, de Azevedo CP, Mendonça ACDF, da Cruz JNM, Frota CC, do Lago BV, Villar LM. Dried blood spot sampling for hepatitis B virus quantification, sequencing and mutation detection. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05264-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wolf JM, Mazeto TK, Pereira VRZB, Simon D, Lunge VR. Recent molecular evolution of hepatitis B virus genotype F in Latin America. Arch Virol. [DOI: 10.1007/s00705-022-05376-z] [Reference Citation Analysis]
9 Hussein M, Berkhout B, Herrera-carrillo E. CRISPR-Cas-Based Gene Therapy to Target Viral Infections. Biotechnologies for Gene Therapy 2022. [DOI: 10.1007/978-3-030-93333-3_5] [Reference Citation Analysis]
10 Xie Y, Ma H, Feng B, Song G. Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase. J Med Virol 2021. [PMID: 34951036 DOI: 10.1002/jmv.27545] [Reference Citation Analysis]
11 Hossain MG, Suwanmanee Y, Du K, Ueda K. Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant. Viruses 2021;13:2328. [PMID: 34835134 DOI: 10.3390/v13112328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
13 Fong TL, Lee BT, Chang M, Nasanbayar K, Tsogtoo E, Boldbaatar D, Dashdorj ED, Clifford NE, Dashdorj AN, Bang BR, Chida T, Lim C, Sugiyama M, Mizokami M, Dashdorj NJ, Liu P, Glenn JS, Dashdorj ND, Saito T. High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California. Dig Dis Sci 2021;66:2833-9. [PMID: 32770488 DOI: 10.1007/s10620-020-06499-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Elpek GO. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World J Clin Cases 2021; 9(19): 4890-4917 [PMID: 34307543 DOI: 10.12998/wjcc.v9.i19.4890] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
15 Campos-Valdez M, Monroy-Ramírez HC, Armendáriz-Borunda J, Sánchez-Orozco LV. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability. Viruses 2021;13:1167. [PMID: 34207116 DOI: 10.3390/v13061167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Wolf JM, Simon D, Lunge VR. Hepatitis B virus genotypes in Brazil: Introduction and dissemination. Infect Genet Evol 2021;93:104936. [PMID: 34023512 DOI: 10.1016/j.meegid.2021.104936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Jeong H, Kim DH, Choi YM, Choi H, Kim D, Kim BJ. rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome. Microorganisms 2021;9:601. [PMID: 33803998 DOI: 10.3390/microorganisms9030601] [Reference Citation Analysis]
18 Mbamalu C, Ekejindu I, Enweani I, Kalu S, Igwe D, Akaeze G. Hepatitis B virus precore/core region mutations and genotypes among hepatitis B virus chronic carriers in South-Eastern, Nigeria. Int J Health Sci (Qassim) 2021;15:26-38. [PMID: 33708042] [Reference Citation Analysis]
19 Yang H, Su T. Viral and Host Factors Affecting Disease Progression of Hepatitis B Virus Infection. Hepatitis B Virus and Liver Disease 2021. [DOI: 10.1007/978-981-16-3615-8_9] [Reference Citation Analysis]
20 Ely A, Singh P, Smith TS, Arbuthnot P. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Adv Drug Deliv Rev 2021;168:134-46. [PMID: 32485207 DOI: 10.1016/j.addr.2020.05.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Lee J, Tsai K, Ou JJ. Mechanisms of Hepatitis B Virus-Induced Hepatocarcinogenesis. In: Wu T, Chang M, Jeang K, editors. Viruses and Human Cancer. Cham: Springer International Publishing; 2021. pp. 47-70. [DOI: 10.1007/978-3-030-57362-1_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pujol F, Jaspe RC, Loureiro CL, Chemin I. Hepatitis B virus American genotypes: Pathogenic variants ? Clin Res Hepatol Gastroenterol 2020;44:825-35. [PMID: 32553521 DOI: 10.1016/j.clinre.2020.04.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
23 Husseini AA, Islam Saeed KM, Yurdcu E, Bozdayı AM. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turk J Gastroenterol 2020;31:658-66. [PMID: 33090103 DOI: 10.5152/tjg.2020.19169] [Reference Citation Analysis]
24 Aguilera A, Trastoy R, Rodríguez-Frias F, Muñoz-Bellido JL, Melón S, Suárez A, Orduña A, Viciana I, Bernal S, García-Bujalance S, Montiel N, Molina JM, Basaras M, Fernández-Cuenca F, García-Arata I, Reina G, Ocete MD, Fuentes A, Navarro-de la Cruz D, Nieto L, Blazquez de Castro A, Buti M, Álvarez M, García F. GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016). J Infect 2020;81:600-6. [PMID: 32711039 DOI: 10.1016/j.jinf.2020.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Inoue T, Tanaka Y. Cross-Protection of Hepatitis B Vaccination among Different Genotypes. Vaccines (Basel) 2020;8:E456. [PMID: 32824318 DOI: 10.3390/vaccines8030456] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
26 Jeong GU, Ahn BY, Jung J, Kim H, Kim TH, Kim W, Lee A, Lee K, Kim JH. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One 2020;15:e0236704. [PMID: 32790777 DOI: 10.1371/journal.pone.0236704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Wolf JM, Pereira VRZB, De Carli S, Godoi TPM, Wortmann AC, Stumm GZ, Galvan J, Soldera J, Simon D, Lunge VR. Tracing back hepatitis B virus genotype D introduction and dissemination in South Brazil. Infection, Genetics and Evolution 2020;82:104294. [DOI: 10.1016/j.meegid.2020.104294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Abe H, Ushijima Y, Bikangui R, Loembe MM, Agnandji ST, de Vries SG, Grobusch MP, Lell B, Yasuda J. Ongoing evolution of hepatitis B virus during viremia in patients with febrile in Central Africa. J Med Virol 2020;92:251-6. [PMID: 31538666 DOI: 10.1002/jmv.25598] [Reference Citation Analysis]
29 Ogawa M, Kamimura S, Kanda T, Takahashi H, Mizutani T, Matsumoto N, Yamamoto T, Nirei K, Matsuoka S, Takei M, Moriyama M. Long-term follow-up of a Japanese patient with hepatitis B virus genotype H and human immunodeficiency virus coinfection. Future Virology 2019;14:633-9. [DOI: 10.2217/fvl-2019-0089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sagnelli C, Sagnelli E. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World J Clin Infect Dis 2019; 9(2): 11-22 [DOI: 10.5495/wjcid.v9.i2.11] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Lee SY, Choi YM, Oh SJ, Yang SB, Lee J, Choe WH, Kook YH, Kim BJ. rt269I Type of Hepatitis B Virus (HBV) Leads to HBV e Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections. Front Immunol 2019;10:1735. [PMID: 31402915 DOI: 10.3389/fimmu.2019.01735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 Limeres MJ, Gomez ER, Noseda DG, Cerrudo CS, Ghiringhelli PD, Nusblat AD, Cuestas ML. Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4. Arch Virol 2019;164:2297-307. [PMID: 31267215 DOI: 10.1007/s00705-019-04332-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ahmad AE, Bakari AG, Musa BOP, Mustapha SK, Jamoh BY, Abdullahi IN, Tahir MI, Olatunji AO, Maishanu SH, Suleiman AB, Tolulope A, Hawkins C, Sagay AS, Zoakah A, Olayinka AT. Pattern of prevalent Hepatitis B virus genotypes in Zaria, Nigeria. Niger Postgrad Med J 2019;26:80-6. [PMID: 31187746 DOI: 10.4103/npmj.npmj_59_19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
34 Wong TC, Fung JY, Cui TY, Lam AH, Dai JW, Chan AC, Cheung TT, Chok KS, Ng KK, Lo CM. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis. J Hepatol 2019;70:1114-22. [PMID: 30871981 DOI: 10.1016/j.jhep.2019.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
35 Taghiabadi M, Hosseini SY, Gorzin AA, Taghavi SA, Monavari SHR, Sarvari J. Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clin Exp Hepatol 2019;5:161-8. [PMID: 31501793 DOI: 10.5114/ceh.2019.84781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ababneh NA, Sallam M, Kaddomi D, Attili AM, Bsisu I, Khamees N, Khatib A, Mahafzah A. Patterns of hepatitis B virus S gene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan. PeerJ 2019;7:e6583. [PMID: 30867996 DOI: 10.7717/peerj.6583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Pettersson JH, Myking S, Elshaug H, Bygdås KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis 2019;19:236. [PMID: 30845915 DOI: 10.1186/s12879-019-3868-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Kostyushev D, Brezgin S, Kostyusheva A, Zarifyan D, Goptar I, Chulanov V. Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus. Cell Mol Life Sci. 2019;76:1779-1794. [PMID: 30673820 DOI: 10.1007/s00018-019-03021-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
39 Groc S, Abbate JL, Le Gal F, Gerber A, Tuaillon E, Albert JL, Nkoghé D, Leroy EM, Roche B, Becquart P. High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon. J Viral Hepat 2019;26:170-82. [PMID: 30141209 DOI: 10.1111/jvh.12991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
40 Makvandi M, Soleimani Jelodar R, Samarbafzadeh A, Neisi N, Sharifi Z, Gholampour A, Masjedizadeh A, Shayesteh A. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran. Asian Pac J Cancer Prev 2018;19:2125-9. [PMID: 30139211 DOI: 10.22034/APJCP.2018.19.8.2125] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Bannister EG, Yuen L, Littlejohn M, Edwards R, Sozzi V, Colledge D, Li X, Locarnini S, Hardikar W, Revill PA. Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome. J Gen Virol 2018;99:1103-14. [PMID: 29932395 DOI: 10.1099/jgv.0.001086] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
42 Sagnelli C, Ciccozzi M, Alessio L, Cella E, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Capoprese M, Occhiello L, Angeletti S, Scotto G, Macera M, Sagnelli E, Coppola N. HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection. 2018;46:523-531. [PMID: 29796738 DOI: 10.1007/s15010-018-1153-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
43 Bello-López JM, Delgado-Balbuena L, Rojas-Huidobro D, Rojo-Medina J. Treatment of platelet concentrates and plasma with riboflavin and UV light: Impact in bacterial reduction. Transfus Clin Biol 2018;25:197-203. [PMID: 29656962 DOI: 10.1016/j.tracli.2018.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
44 Sauvage V, Boizeau L, Candotti D, Vandenbogaert M, Servant-Delmas A, Caro V, Laperche S. Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples. PLoS One 2018;13:e0194366. [PMID: 29566006 DOI: 10.1371/journal.pone.0194366] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
45 Lee SA, Lee SY, Choi YM, Kim H, Kim BJ. Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region. World J Gastroenterol 2018; 24(10): 1084-1092 [PMID: 29563753 DOI: 10.3748/wjg.v24.i10.1084] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Ogura N, Ogawa K, Watashi K, Ito T, Wakita T. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line. Biochem Biophys Res Commun 2018;498:64-71. [PMID: 29481805 DOI: 10.1016/j.bbrc.2018.02.175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Van Damme P, Ward JW, Shouval D, Zanetti A. Hepatitis B Vaccines. Plotkin's Vaccines 2018. [DOI: 10.1016/b978-0-323-35761-6.00025-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
48 Schwarz KB, Li H. Viral Hepatitis in Children. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00065-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Yang H. Viral Factors Affecting Disease Progression. Hepatitis B Virus and Liver Disease 2018. [DOI: 10.1007/978-981-10-4843-2_6] [Reference Citation Analysis]
50 Ničković V, Katanić R, Katanić N, Kocić I. CHRONIC HEPATITIS B. amm 2017;56:50-60. [DOI: 10.5633/amm.2017.0408] [Reference Citation Analysis]
51 Siddiqui ZI, Farooqui SR, Azam SA, Afroz M, Wajid S, Parveen S, Kazim SN. A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma. J Viral Hepat 2017;24:1121-31. [PMID: 28654219 DOI: 10.1111/jvh.12747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
52 Gori A, Gheorgita S, Spinu C, Pinzaru I, Halacu A, Sajen O, Suveica L, Sausy A, Muller CP, Hübschen JM. Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova. Arch Virol 2018;163:431-8. [PMID: 29119358 DOI: 10.1007/s00705-017-3632-6] [Reference Citation Analysis]
53 Pyrski M, Rugowska A, Wierzbiński KR, Kasprzyk A, Bogusiewicz M, Bociąg P, Samardakiewicz S, Czyż M, Kurpisz M, Pniewski T. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered. Vaccine 2017;35:5714-21. [DOI: 10.1016/j.vaccine.2017.07.082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
54 Schulz TR, Edwards R, Thurnheer MC, Yuen L, Littlejohn M, Revill P, Chu M, Tanyeri F, Wade A, Biggs BA, Sasadeusz J. Hepatitis B among immigrants from Myanmar: Genotypes and their clinical relevance. J Med Virol 2018;90:271-6. [PMID: 28885711 DOI: 10.1002/jmv.24939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
55 Sagnelli E, Alessio L, Sagnelli C, Gualdieri L, Pisaturo M, Minichini C, Caprio GD, Starace M, Onorato L, Macera M, Scotto G, Coppola N. Hepatitis B Virus Genotypes, Epidemiological Characteristics and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.13740] [Reference Citation Analysis]
56 Hagiwara S, Nishida N, Park AM, Komeda Y, Sakurai T, Watanabe T, Kudo M. Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis. Sci Rep 2017;7:10440. [PMID: 28874700 DOI: 10.1038/s41598-017-10570-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Takano T, Tajiri H, Hosono S, Inui A, Murakami J, Ushijima K, Miyoshi Y, Etani Y, Abukawa D, Suzuki M, Brooks S. Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission. J Gastroenterol 2017;52:1041-50. [PMID: 28184998 DOI: 10.1007/s00535-017-1315-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
58 Liu WC, Wu IC, Lee YC, Lin CP, Cheng JH, Lin YJ, Yen CJ, Cheng PN, Li PF, Cheng YT, Cheng PW, Sun KT, Yan SL, Lin JJ, Yang JC, Chang KC, Ho CH, Tseng VS, Chang BC, Wu JC, Chang TT. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus. J Pathol 2017;243:176-92. [PMID: 28696069 DOI: 10.1002/path.4938] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
59 Matsuo J, Do SH, Yamamoto C, Nagashima S, Chuon C, Katayama K, Takahashi K, Tanaka J. Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family. PLoS One 2017;12:e0177248. [PMID: 28753615 DOI: 10.1371/journal.pone.0177248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
60 Yano Y, Seo Y, Hayashi H, Hatazawa Y, Hirano H, Minami A, Kawano Y, Saito M, Ninomiya T, Sugano M, Yamada H, Kitajima N, Yoon S, Hayashi Y. Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective? Biomed Rep 2017;7:257-62. [PMID: 28819561 DOI: 10.3892/br.2017.944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Yan LB, Zhu X, Bai L, Tang XQ, Du LY, Chen EQ, Liang LB, Tang H. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B. Clin Res Hepatol Gastroenterol 2017;41:296-302. [PMID: 27988305 DOI: 10.1016/j.clinre.2016.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
62 Sagnelli E, Alessio L, Sagnelli C, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Macera M, Scotto G, Coppola N. Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.13260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
63 Gencay M, Hübner K, Gohl P, Seffner A, Weizenegger M, Neofytos D, Batrla R, Woeste A, Kim HS, Westergaard G, Reinsch C, Brill E, Thu Thuy PT, Hoang BH, Sonderup M, Spearman CW, Pabinger S, Gautier J, Brancaccio G, Fasano M, Santantonio T, Gaeta GB, Nauck M, Kaminski WE. Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population. PLoS One 2017;12:e0172101. [PMID: 28472040 DOI: 10.1371/journal.pone.0172101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
64 Seremba E, Van Geertruyden JP, Ssenyonga R, Opio CK, Kaducu JM, Sempa JB, Colebunders R, Ocama P. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda. Vaccine 2017;35:2937-42. [PMID: 28434689 DOI: 10.1016/j.vaccine.2017.04.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
65 Castelain S, Descamps V, Brochot E, Helle F, Duverlie G, Nguyen-Khac E, François C. High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients. Arch Virol 2017;162:1913-20. [PMID: 28289975 DOI: 10.1007/s00705-017-3312-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minichini C, Di Caprio G, Starace M, Onorato L, Signoriello G, Macera M, Angelillo IF, Pasquale G, Sagnelli E. Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6:33. [PMID: 28179020 DOI: 10.1186/s40249-016-0228-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
67 Chen F, Zhang J, Guo F, Wen B, Luo S, Yuan D, Lin Y, Ou W, Tang P, Dai G, Li F, Liu W, Qu X. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. J Gastroenterol Hepatol 2017;32:515-20. [PMID: 27248508 DOI: 10.1111/jgh.13460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
68 Getahun A, Baekalia M, Panda N, Lee A, Puiahi E, Khan S, Tahani D, Manongi D. Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015. World J Hepatol 2016;8:1521-8. [PMID: 28008343 DOI: 10.4254/wjh.v8.i34.1521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
69 Datta S, Chakravarty R. Role of RNA secondary structure in emergence of compartment specific hepatitis B virus immune escape variants. World J Virol 2016; 5(4): 161-169 [PMID: 27878103 DOI: 10.5501/wjv.v5.i4.161] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Ospelnikova TP, Noseikina EM, Gaiderova LA, Ershov FI. THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY. Journal of microbiology, epidemiology and immunobiology 2016;93:109-121. [DOI: 10.36233/0372-9311-2016-5-109-121] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016;3:420-37. [PMID: 28357379 DOI: 10.15698/mic2016.09.527] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
72 Duan BW, Lu SC, Lai W, Liu XE, Liu Y. The detection of (total and ccc) HBV DNA in liver transplant recipients with hepatitis B vaccine against HBV reinfection. Hum Vaccin Immunother 2015;11:2490-4. [PMID: 26177383 DOI: 10.1080/21645515.2015.1063755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
73 Andriamandimby SF, Lo Presti A, Lai A, Olive MM, Angeletti S, De Florio L, Cella E, Razafindramparany M, Ravalohery JP, Andriamamonjy S, Gioffrè S, Zehender G, Mottini G, Ciccozzi M, Heraud JM. Genetic diversity of hepatitis B virus (HBV) in Madagascar. J Med Virol 2016;88:2138-44. [PMID: 27183503 DOI: 10.1002/jmv.24576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
74 Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, Laperche S, Sanogo R, Allain JP, Simpore J. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections. J Med Virol. 2016;88:2145-2156. [PMID: 27253483 DOI: 10.1002/jmv.24589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
75 Cornelissen M, Zorgdrager F, Bruisten SM, Bakker M, Berkhout B, van der Kuyl AC. Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men. BMC Infect Dis 2016;16:268. [PMID: 27286832 DOI: 10.1186/s12879-016-1599-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
76 Alavian SM, Imanieh MH, Imanieh MH. Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections. Hepat Mon 2016;16:e34790. [PMID: 27330536 DOI: 10.5812/hepatmon.34790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
77 Escobar-Escamilla N, Fragoso-Fonseca DE, Arreguín-Porras DM, Esteban-Valencia Mdel C, Corona-Valdespino E, Falcón-Acosta JI, Vázquez-Campuzano R, Garcés-Ayala F, Ortiz-Alcantara JM, López-Martinez I, Diaz-Quiñonez JA, Ramírez-González JE. Complete Genome Sequence of Hepatitis B Virus Genotype E, the First Molecular Characterization from an Imported Case in Mexico. Genome Announc 2016;4:e00187-16. [PMID: 27034495 DOI: 10.1128/genomeA.00187-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Cai Q, Zhu H, Zhang Y, Li X, Zhang Z. Hepatitis B virus genotype A: design of reference sequences for sub-genotypes. Virus Genes 2016;52:325-33. [PMID: 27002608 DOI: 10.1007/s11262-016-1307-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
79 Yang Z, Zhuang L, Lu Y, Xu Q, Tang B, Chen X. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis. Oncotarget 2016;7:12525-36. [PMID: 26848866 DOI: 10.18632/oncotarget.7123] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
80 Oliveira MP, Lemes PS, Matos MAD, Del-rios NHA, Santos Carneiro MA, Costa Silva ÁM, Lopes CLR, Teles SA, Aires RS, Lago BV, Araujo NM, Martins RMB. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil: HBV in HIV-Infected Patients in Brazil. J Med Virol 2016;88:1222-9. [DOI: 10.1002/jmv.24462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
81 Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22(1): 145-154 [PMID: 26755866 DOI: 10.3748/wjg.v22.i1.145] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 100] [Article Influence: 13.6] [Reference Citation Analysis]
82 Zirabamuzale JT, Opio CK, Bwanga F, Seremba E, Apica BS, Colebunders R, Ocama P. Hepatitis B virus genotypes A and D in Uganda. J Virus Erad 2016;2:19-21. [PMID: 27482430] [Reference Citation Analysis]
83 Zirabamuzale JT, Opio CK, Bwanga F, Seremba E, Apica BS, Colebunders R, Ocama P. Hepatitis B virus genotypes A and D in Uganda. Journal of Virus Eradication 2016;2:19-21. [DOI: 10.1016/s2055-6640(20)30693-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
84 Asahina Y, Watanabe M. Need for appropriate programs for prevention of hepatitis B infection: Lessons from the latest nationwide survey in Japan. J Gastroenterol Hepatol 2016;31:12-3. [PMID: 26780982 DOI: 10.1111/jgh.13157] [Reference Citation Analysis]
85 Bragazzi NL, Amicizia D, Panatto D, Tramalloni D, Valle I, Gasparini R. Quartz-Crystal Microbalance (QCM) for Public Health: An Overview of Its Applications. Adv Protein Chem Struct Biol 2015;101:149-211. [PMID: 26572979 DOI: 10.1016/bs.apcsb.2015.08.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
86 Gu L, Han Y, Li Y, Zhu T, Song X, Huang Y, Yang F, Guan S, Xie J, Gohda J, Hosoya N, Kawana-Tachikawa A, Liu W, Gao GF, Iwamoto A, Li T, Ishida T. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLoS One 2015;10:e0134539. [PMID: 26288093 DOI: 10.1371/journal.pone.0134539] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
87 Cordero-Coma M, Salazar-Méndez R, Yilmaz T. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues. Expert Opin Drug Saf 2015;14:1353-71. [PMID: 26118392 DOI: 10.1517/14740338.2015.1061992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
88 Kim J, Choi H, Kim T, Kim SI. A Study on the Anxiety of the Chronic Viral Hepatitis Patients Receiving Pegylated Interferon Therapy. J Korean Neuropsychiatr Assoc 2015;54:506. [DOI: 10.4306/jknpa.2015.54.4.506] [Reference Citation Analysis]